5-fluorotryptamine monohydrochloride has been researched along with ritanserin in 1 studies
| Studies (5-fluorotryptamine monohydrochloride) | Trials (5-fluorotryptamine monohydrochloride) | Recent Studies (post-2010) (5-fluorotryptamine monohydrochloride) | Studies (ritanserin) | Trials (ritanserin) | Recent Studies (post-2010) (ritanserin) |
|---|---|---|---|---|---|
| 6 | 0 | 2 | 735 | 75 | 71 |
| Protein | Taxonomy | 5-fluorotryptamine monohydrochloride (IC50) | ritanserin (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0012 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.001 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.047 | |
| Diacylglycerol kinase alpha | Homo sapiens (human) | 9 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.047 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0025 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0025 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.0012 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0025 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.047 | |
| D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.012 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
1 other study(ies) available for 5-fluorotryptamine monohydrochloride and ritanserin
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |